CN110585214A - Nano particles for promoting effect of treating tumor and synthesis method thereof - Google Patents

Nano particles for promoting effect of treating tumor and synthesis method thereof Download PDF

Info

Publication number
CN110585214A
CN110585214A CN201910911910.8A CN201910911910A CN110585214A CN 110585214 A CN110585214 A CN 110585214A CN 201910911910 A CN201910911910 A CN 201910911910A CN 110585214 A CN110585214 A CN 110585214A
Authority
CN
China
Prior art keywords
ultrasonic treatment
solution
tirapazamine
tumor
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910911910.8A
Other languages
Chinese (zh)
Inventor
易昌凤
张宏量
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei University
Original Assignee
Hubei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University filed Critical Hubei University
Priority to CN201910911910.8A priority Critical patent/CN110585214A/en
Publication of CN110585214A publication Critical patent/CN110585214A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a nano particle for promoting the effect of treating tumor and a synthetic method thereof, wherein the synthetic method comprises the following steps: dissolving tirapazamine in polyvinyl alcohol, performing ultrasonic treatment to obtain a solution A, dissolving carbonyl manganese and PLGA in dichloromethane under an ice bath condition, performing ultrasonic treatment to obtain a solution B, dripping the solution B into the solution A under the ice bath condition, adding a product obtained after ultrasonic treatment into the polyvinyl alcohol solution, performing ultrasonic treatment, diluting and stirring to obtain a final product. The invention uses a brand new design idea, the complex manganese carbonyl is used in the synthesis process, the synthesized nano particles can release carbon monoxide (CO) at the tumor part, the CO not only can achieve good treatment effect, but also can promote aerobic respiration of tumor cells and oxygen consumption, and further promote the efficient use of tirapazamine.

Description

Nano particles for promoting effect of treating tumor and synthesis method thereof
Technical Field
The invention relates to the technical field of biological targeting nano-medicines, in particular to a nano-particle for promoting the effect of treating tumors and a synthesis method thereof.
Background
Tumor hypoxia is a common feature of solid tumors in humans and animals, is a powerful negative clinical biomarker, and is considered to be one of the most effective therapeutic targets in cancer therapy. On the one hand, tumor hypoxia is a major factor leading to the failure of many anticancer therapies. On the other hand, tumor hypoxia may be an attractive therapeutic target, as it underlies the major difference between tumor and normal tissues. Hypoxia-activated drugs (HAPs) are selectively highly toxic to hypoxic cells and less toxic in areas of higher oxygen tension, such as normal tissue. Thus, HAP has the potential to selectively kill hypoxic cells, thereby converting tumor hypoxia from a problem to a selective therapeutic advantage. Tirapazamine (tpz), tirapazamine, a representative HAP, exhibits up to 300-fold higher toxicity in mouse and human cancer cell lines under hypoxic conditions than aerobic conditions in vitro. As a prodrug, TPZ can be stimulated under hypoxic conditions to produce a transient oxidative radical intermediate via a one-electron reduction reaction.
Although the tumor area is an oxygen-deficient environment, it is still insufficient to activate the TPZ effect, and it is a question to decrease the oxygen concentration in the tumor area and thus improve the treatment effect of TPZ, such as the treatment scheme using PDT in combination with TPZ, where PDT is an oxygen-consuming treatment scheme that consumes part of the oxygen and thus improves the treatment effect of TPZ. In the experiment, a brand new design idea is adopted, the complex manganese carbonyl is used, carbon monoxide (CO) is released at the tumor part, the CO not only can achieve a good treatment effect, but also can promote aerobic respiration of tumor cells, consume oxygen and further promote efficient use of TPZ.
Disclosure of Invention
The invention aims to overcome the defects in the prior art, and provides a nano particle for promoting the effect of treating tumors and a synthesis method thereof, which promote aerobic respiration of tumor cells, consume oxygen, promote efficient use of tirapazamine and achieve better treatment effect.
The invention is realized by the following steps: a method for synthesizing nanoparticles for promoting the effect of treating tumors comprises the following steps:
step one, weighing 1mg of tirapazamine, dissolving the tirapazamine in 1mL of polyvinyl alcohol with the concentration of 20mg/mL, and performing ultrasonic treatment to promote dissolution to obtain a standby solution A;
weighing 20mg of manganese carbonyl and 50mg of PLGA, dissolving in 4mL of dichloromethane, and performing ultrasonic treatment under an ice bath condition to promote dissolution to obtain a standby solution B;
step three, dropwise adding the standby solution B prepared in the step two into the standby solution A prepared in the step one, and carrying out ultrasonic treatment under the ice bath condition;
step four, adding the product obtained in the step three into 12mL of PVA solution with the concentration of 50mg/mL, carrying out ultrasonic treatment, transferring the product into 100mL of deionized water, and stirring the mixture for 12 hours to obtain the final product.
Further, in the ultrasonic treatment in the first step to the fourth step, the ultrasonic power is 400W, and the ultrasonic time is 60 min.
The nano particle for promoting the effect of treating the tumor is prepared by the method.
The invention has the following beneficial effects:
the advantage of this experiment is that a new method is proposed to exacerbate the degree of hypoxia at the tumor site, thereby promoting the action of TPZ drugs. Due to the fact that the carbonyl manganese is used, due to the fact that the high hydrogen peroxide concentration in the tumor cells can promote decomposition of the carbonyl manganese to generate CO, according to relevant literature reports, the CO can promote aerobic respiration of the tumor cells, the CO can achieve the purpose of killing the tumor cells, meanwhile, the oxygen concentration in a tumor area is reduced, and conditions are provided for activation of TPZ medicines.
Drawings
FIG. 1 is an electron microscope image of the prepared nanoparticles;
FIG. 2 is the hydrated particle size of the synthesized microspheres;
FIG. 3 is a graph of the activity of tumor cells under the action of three types of particles, the x-axis representing the concentration of manganese carbonyls and tirapazamine, and the y-axis representing the survival rate of tumor cells;
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Step one, weighing 1mg of tirapazamine, dissolving the tirapazamine in 1mL of polyvinyl alcohol with the concentration of 20mg/mL, and performing ultrasonic treatment to promote dissolution to obtain a standby solution A;
weighing 20mg of manganese carbonyl and 50mg of PLGA, dissolving in 4mL of dichloromethane, and performing ultrasonic treatment under an ice bath condition to promote dissolution to obtain a standby solution B;
step three, dropwise adding the standby solution B prepared in the step two into the standby solution A prepared in the step one, and carrying out ultrasonic treatment under the ice bath condition;
step four, adding the product obtained in the step three into 12mL of PVA solution with the concentration of 50mg/mL, carrying out ultrasonic treatment, transferring the product into 100mL of deionized water, and stirring the mixture for 12 hours to obtain the final product.
Ultrasonic treatment in the first step to the fourth step, wherein the ultrasonic power is 400W, and the ultrasonic time is 60 min.
The nanoparticle TPZ/CO-PLGA for promoting the effect of treating the tumor is prepared by the method.
Example 2
The shape and structure of the prepared nano particles are researched:
the nanoparticles were observed to have a spherical structure around 100nm under a transmission electron microscope, see fig. 1.
Example 3
By studying the hydrated particle size of the nanoparticle, see fig. 2, it is known that the hydrated particle size of the PLGA microsphere synthesized by the present invention is about 110 nm.
Example 4
The change of the survival rate of the tumor cells under the action of the three particles is researched. It can be seen from figure 3 that the best therapeutic effect is achieved when CO is combined with TPZ. Indicating that CO has an interaction promoting effect with TPZ.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (3)

1. A method for synthesizing nanoparticles for promoting the effect of treating tumors is characterized by comprising the following steps:
step one, weighing 1mg of tirapazamine, dissolving the tirapazamine in 1mL of polyvinyl alcohol with the concentration of 20mg/mL, and performing ultrasonic treatment to promote dissolution to obtain a standby solution A;
weighing 20mg of manganese carbonyl and 50mg of PLGA, dissolving in 4mL of dichloromethane, and performing ultrasonic treatment under an ice bath condition to promote dissolution to obtain a standby solution B;
step three, dropwise adding the standby solution B prepared in the step two into the standby solution A prepared in the step one, and carrying out ultrasonic treatment under the ice bath condition;
step four, adding the product obtained in the step three into 12mL of PVA solution with the concentration of 50mg/mL, carrying out ultrasonic treatment, transferring the product into 100mL of deionized water, and stirring the mixture for 12 hours to obtain the final product TPZ/CO-PLGA.
2. The method for synthesizing nanoparticles for promoting tumor treatment according to claim 1, wherein the ultrasound treatment in the first step, the second step, the third step and the fourth step is performed at an ultrasound power of 400W for an ultrasound time of 60 min.
3. A nanoparticle for promoting tumor treatment effect prepared by the method of any one of claims 1-2.
CN201910911910.8A 2019-09-25 2019-09-25 Nano particles for promoting effect of treating tumor and synthesis method thereof Pending CN110585214A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910911910.8A CN110585214A (en) 2019-09-25 2019-09-25 Nano particles for promoting effect of treating tumor and synthesis method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910911910.8A CN110585214A (en) 2019-09-25 2019-09-25 Nano particles for promoting effect of treating tumor and synthesis method thereof

Publications (1)

Publication Number Publication Date
CN110585214A true CN110585214A (en) 2019-12-20

Family

ID=68863425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910911910.8A Pending CN110585214A (en) 2019-09-25 2019-09-25 Nano particles for promoting effect of treating tumor and synthesis method thereof

Country Status (1)

Country Link
CN (1) CN110585214A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009126705A2 (en) * 2008-04-10 2009-10-15 Virginia Commonwealth University Induction of tumor hypoxia for cancer therapy
CN108126198A (en) * 2017-12-26 2018-06-08 南京鼓楼医院 A kind of W18O49Tirapazamine composite nanoparticle and preparation method and application
CN108434462A (en) * 2018-03-13 2018-08-24 中山大学 A kind of multifunctional nano diagnosis and treatment agent and the preparation method and application thereof of mesoporous poly-dopamine load manganese carbonyl
CN108721321A (en) * 2017-04-19 2018-11-02 深圳大学 A kind of nanometer diagnosis and treatment agent of cancer target, Its Preparation Method And Use
CN109846856A (en) * 2019-04-04 2019-06-07 南京工业大学 Bio-enzyme catalysis gas production anti-tumor bionic nanoparticle and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009126705A2 (en) * 2008-04-10 2009-10-15 Virginia Commonwealth University Induction of tumor hypoxia for cancer therapy
US20120087913A1 (en) * 2008-04-10 2012-04-12 Lee Ruey-Min Induction of tumor hypoxia for cancer therapy
CN108721321A (en) * 2017-04-19 2018-11-02 深圳大学 A kind of nanometer diagnosis and treatment agent of cancer target, Its Preparation Method And Use
CN108126198A (en) * 2017-12-26 2018-06-08 南京鼓楼医院 A kind of W18O49Tirapazamine composite nanoparticle and preparation method and application
CN108434462A (en) * 2018-03-13 2018-08-24 中山大学 A kind of multifunctional nano diagnosis and treatment agent and the preparation method and application thereof of mesoporous poly-dopamine load manganese carbonyl
CN109846856A (en) * 2019-04-04 2019-06-07 南京工业大学 Bio-enzyme catalysis gas production anti-tumor bionic nanoparticle and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LI, YJ ET AL,: ""Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction",", 《BIOMATERIALS》 *

Similar Documents

Publication Publication Date Title
Yang et al. Nanozymes: activity origin, catalytic mechanism, and biological application
Li et al. ROS‐catalytic transition‐metal‐based enzymatic nanoagents for tumor and bacterial eradication
Feng et al. Spherical mesoporous Fe-NC single-atom nanozyme for photothermal and catalytic synergistic antibacterial therapy
Tang et al. Biomedicine meets Fenton chemistry
Liu et al. Graphdiyne-templated palladium-nanoparticle assembly as a robust oxygen generator to attenuate tumor hypoxia
Wang et al. In situ fabrication of metal-organic framework derived hybrid nanozymes for enhanced nanozyme-photothermal therapy of bacteria-infected wounds
Li et al. Exo/endogenous dual-augmented chemodynamic therapy based on bio-reducible and bio-breakable copper (Ⅱ)-based truncated octahedron
Zhang et al. X-ray-facilitated redox cycling of nanozyme possessing peroxidase-mimicking activity for reactive oxygen species-enhanced cancer therapy
Gong et al. Engineering Cu-CuFe2O4 nanoenzyme for hypoxia-relief and GSH-depletion enhanced chemodynamic/sonodynamic therapy
Qiao et al. Engineering defected 2D Pd/H-TiO2 nanosonosensitizers for hypoxia alleviation and enhanced sono-chemodynamic cancer nanotherapy
Wang et al. Preparation of sonoactivated TiO2-DVDMS nanocomposite for enhanced antibacterial activity
Gao et al. 3D CNT/MXene microspheres for combined photothermal/photodynamic/chemo for cancer treatment
Wang et al. Hollow Co-CeO2@ PEG nanospheres: Ultrasound enhanced cascade-nanozyme for synergetic anticancer
Zhang et al. Photococatalytic anticancer performance of naked Ag/AgCl nanoparticles
Cheng et al. 4-in-1 Fe3O4/g-C3N4@ PPy-DOX nanocomposites: magnetic targeting guided trimode combinatorial chemotherapy/PDT/PTT for cancer
CN109432424B (en) Ultrathin cobalt-manganese hydrotalcite composite photosensitizer and application thereof in tumor treatment and magnetic resonance imaging
Higgins et al. X-ray radiation enhancement of gold-TiO2 nanocomposites
Zhao et al. Which is Better for Nanomedicines: Nanocatalysts or Single‐Atom Catalysts?
Zhao et al. Plasmonic nanobipyramids with photo-enhanced catalytic activity under near-infrared II window for effective treatment of breast cancer
Wei et al. Copper-based nanomaterials for biomedical applications
Tian et al. Revealing Mn doping effect in transition metal phosphides to trigger active centers for highly efficient Chemodynamic and NIR-II Photothermal therapy
Lv et al. Biodegradation Mn-CoS@ carbon di-shell nanoheterostructure with enhanced nanozymemediated phototherapy
Mohammed et al. Harnessing inorganic nanomaterials for chemodynamic cancer therapy
CN113332427A (en) Fe2O3@ Pt multifunctional nano-particle and preparation method and application thereof
CN110559438B (en) Photothermal and photodynamic diagnosis and treatment integrated reagent guided by nuclear magnetic resonance imaging and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191220

RJ01 Rejection of invention patent application after publication